Evaluation of the effect of hypertonic saline3% in the treatment of ECG changes and other side effects of tramadol toxicity
Design
Randomized trial with not blinded in 200 patients ,there is no cotrol group,phase 2-3 on all of the patients
Settings and conduct
Evaluation of the effect of hypertonic saline3% in tramadol side effects with ECG changes in emergency ward of Besat hospital in Tehran
Participants/Inclusion and exclusion criteria
Inclusion criteria: acute tramadol poisoning; aged over 18 years.
Exclusion criteria: severe disorders such as liver cirrhosis, the existence of previous diseases such as dextrocardia or behevioral disorders.
Intervention groups
Effect of hypertonic saline 3%in tramadol side effects in all of the patients,there is no control group
Main outcome variables
Drug dose,QRS widening,long QT,tall R,RBBB,axis deviation
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20220213054017N1
Registration date:2022-03-21, 1401/01/01
Registration timing:registered_while_recruiting
Last update:2022-03-21, 1401/01/01
Update count:0
Registration date
2022-03-21, 1401/01/01
Registrant information
Name
Ebrahim Karimi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2235 3089
Email address
ebrahimkarimi86@ ajaums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-09-23, 1400/07/01
Expected recruitment end date
2022-09-23, 1401/07/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the effect of hypertonic saline 3%in the treatment of ECG changes and other side effects of tramadol toxicity
Public title
Effect of hypertonic saline3% in tramadol toxicity
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Acute tramadol toxicity
Aged over 18 years
Exclusion criteria:
Severe disorders such as liver cirrhosis
Existence of previous diseases such as dextrocardia or behavioral disorders